Zoetis Inc. $ZTS Stock Holdings Lifted by Voya Investment Management LLC

Key Points

• Voya Investment Management LLC increased its stake in Zoetis Inc. by 0.8%, owning approximately 225,506 shares valued at $37.13 million, according to its recent SEC filing.
• Multiple institutional investors, including Vanguard Group Inc. and Polen Capital Management LLC, have also raised their holdings, contributing to 92.80% institutional ownership of Zoetis.
• Zoetis reported better-than-expected earnings, with an EPS of $1.76 for the last quarter, surpassing estimates, and an anticipated FY 2025 guidance range of 6.300-6.400 EPS.

Voya Investment Management LLC raised its stake in Zoetis Inc. (NYSE:ZTS - Free Report) by 0.8% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 225,506 shares of the company's stock after buying an additional 1,809 shares during the period. Voya Investment Management LLC owned approximately 0.05% of Zoetis worth $37,130,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in shares of Zoetis by 0.5% in the first quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company's stock valued at $6,842,222,000 after buying an additional 189,287 shares in the last quarter. Polen Capital Management LLC increased its holdings in shares of Zoetis by 17.6% in the first quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company's stock valued at $1,448,401,000 after buying an additional 1,313,653 shares in the last quarter. Northern Trust Corp increased its holdings in shares of Zoetis by 1.2% in the first quarter. Northern Trust Corp now owns 6,504,902 shares of the company's stock valued at $1,071,032,000 after buying an additional 78,508 shares in the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Zoetis by 2.2% in the first quarter. Goldman Sachs Group Inc. now owns 5,146,024 shares of the company's stock valued at $847,293,000 after buying an additional 109,791 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in shares of Zoetis by 7.6% in the first quarter. Brown Advisory Inc. now owns 4,408,542 shares of the company's stock valued at $725,866,000 after buying an additional 312,746 shares in the last quarter. Institutional investors own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

ZTS has been the topic of several research analyst reports. Stifel Nicolaus cut shares of Zoetis from a "buy" rating to a "hold" rating and lowered their price objective for the stock from $165.00 to $160.00 in a research report on Wednesday, June 18th. Leerink Partnrs cut shares of Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. Leerink Partners cut shares of Zoetis from an "outperform" rating to a "market perform" rating and decreased their price objective for the stock from $180.00 to $155.00 in a report on Thursday, July 17th. Piper Sandler upped their price objective on shares of Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Finally, Argus reaffirmed a "buy" rating and set a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $200.88.

Zoetis Stock Performance

NYSE ZTS opened at $148.33 on Friday. The firm has a market cap of $65.74 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 2.42 and a beta of 0.89. The company has a 50 day moving average of $152.32 and a 200-day moving average of $157.26. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a 1-year low of $139.70 and a 1-year high of $200.33.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The business had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same period in the prior year, the firm earned $1.56 earnings per share. Zoetis's revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. On average, equities analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.